-
1
المؤلفون: Irene M, Shui, Emilie, Scherrer, Andrew, Frederickson, Joyce W, Li, Anel, Mynzhassarova, Eric, Druyts, Hussein, Tawbi
المصدر: Melanoma Research. 32:393-404
مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Oncology, Drug Resistance, Neoplasm, Programmed Cell Death 1 Receptor, Humans, Immunotherapy, Dermatology, Ipilimumab, Melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24277db8ff02d4b150d4a28e6f90efe7Test
https://doi.org/10.1097/cmr.0000000000000850Test -
2
المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar
المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test -
3
المؤلفون: Cathy A Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis
المصدر: Immunotherapy. 14(4)
مصطلحات موضوعية: Male, Databases, Factual, Immunology, Programmed Cell Death 1 Receptor, Middle Aged, Survival Analysis, Cohort Studies, Treatment Outcome, Oncology, Disease Progression, Immunology and Allergy, Humans, Female, Immunotherapy, Melanoma, Aged, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac074913462573af98a533bb5bbc2bdTest
https://pubmed.ncbi.nlm.nih.gov/34870445Test -
4
المؤلفون: Steven M. Townson, James Larkin, Emilie Scherrer, Reina Rau, Irene Shui, Maria Lorenzi
المصدر: Future oncology (London, England). 17(20)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Clinical Decision-Making, Programmed Cell Death 1 Receptor, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Overall survival, Biomarkers, Tumor, Humans, Immune Checkpoint Inhibitors, Melanoma, Advanced melanoma, business.industry, Patient Selection, Anti pd 1, General Medicine, medicine.disease, Progression-Free Survival, 030104 developmental biology, Systematic review, 030220 oncology & carcinogenesis, Biomarker (medicine), business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c394dfb2529278b1dd27e417d8c10cTest
https://pubmed.ncbi.nlm.nih.gov/33783230Test -
5
المؤلفون: Emilie Scherrer, Wanmei Ou, Eric D. Whitman, Clemens Krepler
المصدر: Future oncology (London, England). 16(20)
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, medicine, Humans, In patient, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Anti pd 1, Retrospective cohort study, General Medicine, Immunotherapy, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Retreatment, Female, Outcomes research, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecb7e4b6384a254b88279aeefff942cTest
https://pubmed.ncbi.nlm.nih.gov/32410465Test